• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Patrick Vallance - Articles and news items

GlaxoSmithKline logo

GSK announces phase III study with darapladib did not meet primary endpoint in patients following an acute coronary syndrome

Industry news / 13 May 2014 / GlaxoSmithKline

GlaxoSmithKline announced headline results from its second phase III study with darapladib, SOLID-TIMI 52, evaluating the efficacy of its investigational Lp-PLA2 inhibitor in adults following an acute coronary syndrome…

GlaxoSmithKline logo

Where do you start when developing a new medicine?

Industry news / 27 March 2014 / GlaxoSmithKline

Novel scientific collaboration to use genomics and big data to drive drug discovery…

GlaxoSmithKline logo

GSK receives positive CHMP opinion for Incruse® (umeclidinium) for the treatment of COPD

Industry news / 21 February 2014 / GlaxoSmithKline

GlaxoSmithKline plc announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for umeclidinium under the proposed brand name Incruse®…

GlaxoSmithKline logo

Anoro® (umeclidinium / vilanterol) receives positive opinion from the CHMP in Europe for the treatment of COPD

Industry news / 20 February 2014 / GlaxoSmithKline

GlaxoSmithKline plc and Theravance, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for umeclidinium/vilanterol under the proposed brand name Anoro®…

GlaxoSmithKline logo

FDA Advisory Committee recommends approval in US of umeclidinium/vilanterol for the treatment of COPD

Industry news, News / 10 September 2013 / GlaxoSmithKline

GSK and Theravance, Inc. announced that the PADAC to the US FDA voted 11 yes to 2 no that the efficacy and safety data provide substantial evidence to support approval of umeclidinium/vilanterol…

GlaxoSmithKline logo

GSK supports BMJ commitment on clinical trial data transparency

Industry news, News / 31 October 2012 / GlaxoSmithKline

“GSK fully supports the commitment made by BMJ to drive greater transparency of clinical trial data…”

GlaxoSmithKline logo

London 2012 partner, GlaxoSmithKline, shares scientific expertise with WADA to help fight against abuse of drugs in sport

Industry news, News / 4 July 2011 / GlaxoSmithKline

GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +